Treatment with the poly(ADP-ribose) polymerase inhibitor PJ-34 improves cerebromicrovascular endothelial function, neurovascular coupling responses and cognitive performance in aged mice, supporting the NAD+ depletion hypothesis of neurovascular aging

Publication | Open Access

DOI Full Paper Access

101

Citations

References

2019

Year

Stefano Tarantini, Andriy Yabluchanskiy, Tamás Csípő, Gábor Áron Fülöp, Tamás Kiss, Priya Balasubramanian, Jordan DelFavero, Chetan Ahire, Anna Ungvari, Ádám Nyúl‐Tóth,

GeroScience

Alzheimer's DiseaseAgingLongevityDementiaPhysiologyNad+ Depletion HypothesisMedicinePolymerase Inhibitor Pj-34Vascular BiologyAged MiceNeurologyAging-associated DiseaseVascular AgingPharmacologyAtherosclerosisHealth Sciences